Patterns of Postmastectomy Radiotherapy in Immediate Breast Reconstruction-Results From the iBRA-2 Cohort Study.

IF 1.9 Q4 ONCOLOGY
International Journal of Breast Cancer Pub Date : 2026-05-18 eCollection Date: 2026-01-01 DOI:10.1155/ijbc/5902426
Tim Rattay, Adam Trickey, Rachel L O'Connell, Rajiv V Dave, Joanna Skillman, Nicola L P Barnes, Matthew D Gardiner, Chris Holcombe, Shelley Potter
{"title":"Patterns of Postmastectomy Radiotherapy in Immediate Breast Reconstruction-Results From the iBRA-2 Cohort Study.","authors":"Tim Rattay, Adam Trickey, Rachel L O'Connell, Rajiv V Dave, Joanna Skillman, Nicola L P Barnes, Matthew D Gardiner, Chris Holcombe, Shelley Potter","doi":"10.1155/ijbc/5902426","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Long-term data indicate that postmastectomy radiotherapy (PMRT) is associated with improved overall survival in node-positive breast cancer patients. Immediate breast reconstruction (IBR) remains controversial in the context of planned PMRT, but rates of IBR are increasing. The aim of this study was to examine patterns of PMRT in patients undergoing mastectomy with or without IBR.</p><p><strong>Methods: </strong>Data were collected from 2526 patients enrolled in the iBRA-2 prospective cohort study undergoing 2606 mastectomies with and without IBR between 1 July 2016 and 31 December 2016. Patients were recruited consecutively at 71 centres across the United Kingdom (UK) and Ireland and at five international centres. Univariable and multivariable logistic regression models were used to explore associations between recommendation for PMRT and patient- and procedure-related factors.</p><p><strong>Results: </strong>Of 2590 breast procedures included in the analysis, 696 were implant-based, 105 pedicled-flap and 230 free-flap reconstructions, and 32.5% of implant-based, 34.3% of pedicled-flap and 35.7% of free-flap reconstructions were recommended for PMRT. PMRT recommendation by cancer stage was 21% for T1-2 N0, 65% for T1-2 N1 and 89% for T<sub>any</sub> N2 and T3 N<sub>any</sub>. In multivariable analyses, patients with invasive disease undergoing implant-only reconstruction, but not pedicled-flap or free-flap reconstruction, were less likely to be recommended for PMRT than those undergoing mastectomy alone. The likelihood of being recommended for PMRT differed by region.</p><p><strong>Conclusion: </strong>Although IBR was more likely to be performed for lower-stage cancers and in younger patients with fewer comorbidities, a third of patients undergoing IBR were recommended for PMRT. This adds to a growing body of evidence that IBR is becoming an acceptable option for women requiring PMRT. The study also highlighted regional variation in PMRT practice within the UK and Ireland, which merits further investigation.</p>","PeriodicalId":46159,"journal":{"name":"International Journal of Breast Cancer","volume":"2026 ","pages":"5902426"},"PeriodicalIF":1.9000,"publicationDate":"2026-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13181802/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Breast Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/ijbc/5902426","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Long-term data indicate that postmastectomy radiotherapy (PMRT) is associated with improved overall survival in node-positive breast cancer patients. Immediate breast reconstruction (IBR) remains controversial in the context of planned PMRT, but rates of IBR are increasing. The aim of this study was to examine patterns of PMRT in patients undergoing mastectomy with or without IBR.

Methods: Data were collected from 2526 patients enrolled in the iBRA-2 prospective cohort study undergoing 2606 mastectomies with and without IBR between 1 July 2016 and 31 December 2016. Patients were recruited consecutively at 71 centres across the United Kingdom (UK) and Ireland and at five international centres. Univariable and multivariable logistic regression models were used to explore associations between recommendation for PMRT and patient- and procedure-related factors.

Results: Of 2590 breast procedures included in the analysis, 696 were implant-based, 105 pedicled-flap and 230 free-flap reconstructions, and 32.5% of implant-based, 34.3% of pedicled-flap and 35.7% of free-flap reconstructions were recommended for PMRT. PMRT recommendation by cancer stage was 21% for T1-2 N0, 65% for T1-2 N1 and 89% for Tany N2 and T3 Nany. In multivariable analyses, patients with invasive disease undergoing implant-only reconstruction, but not pedicled-flap or free-flap reconstruction, were less likely to be recommended for PMRT than those undergoing mastectomy alone. The likelihood of being recommended for PMRT differed by region.

Conclusion: Although IBR was more likely to be performed for lower-stage cancers and in younger patients with fewer comorbidities, a third of patients undergoing IBR were recommended for PMRT. This adds to a growing body of evidence that IBR is becoming an acceptable option for women requiring PMRT. The study also highlighted regional variation in PMRT practice within the UK and Ireland, which merits further investigation.

乳房切除术后放疗在即时乳房重建中的模式——来自iBRA-2队列研究的结果。
目的:长期数据表明,乳腺切除术后放疗(PMRT)与提高淋巴结阳性乳腺癌患者的总生存率相关。即刻乳房重建(IBR)在计划PMRT的背景下仍然存在争议,但IBR的比率正在增加。本研究的目的是检查有或没有IBR的乳房切除术患者的PMRT模式。方法:在2016年7月1日至2016年12月31日期间,入选iBRA-2前瞻性队列研究的2526例患者接受了2606例伴有或不伴有IBR的乳房切除术。在英国和爱尔兰的71个中心以及5个国际中心连续招募患者。单变量和多变量logistic回归模型用于探讨PMRT推荐与患者和手术相关因素之间的关系。结果:在纳入分析的2590例乳房手术中,696例为植入式,105例为带蒂皮瓣重建,230例为自由皮瓣重建,32.5%的植入式,34.3%的带蒂皮瓣和35.7%的自由皮瓣重建被推荐用于PMRT。T1-2 N0的PMRT推荐率为21%,T1-2 N1为65%,Tany N2和T3 Nany为89%。在多变量分析中,侵袭性疾病患者只接受植入物重建,而不接受带蒂皮瓣或自由皮瓣重建,与单独接受乳房切除术的患者相比,推荐进行PMRT的可能性更小。被推荐进行PMRT的可能性因地区而异。结论:尽管IBR更可能用于低期癌症和合并症较少的年轻患者,但三分之一接受IBR的患者被推荐用于PMRT。这增加了越来越多的证据,表明IBR正在成为需要PMRT的妇女可接受的选择。该研究还强调了英国和爱尔兰的PMRT实践的地区差异,这值得进一步调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.40
自引率
0.00%
发文量
25
审稿时长
19 weeks
期刊介绍: International Journal of Breast Cancer is a peer-reviewed, Open Access journal that provides a forum for scientists, clinicians, and health care professionals working in breast cancer research and management. The journal publishes original research articles, review articles, and clinical studies related to molecular pathology, genomics, genetic predisposition, screening and diagnosis, disease markers, drug sensitivity and resistance, as well as novel therapies, with a specific focus on molecular targeted agents and immune therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书